Concepedia
Statistics
Publications
32
Citations
1.4K
H-Index
23
Active since
1984
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
Bicycle Therapeutics (United Kingdom)
University of Sussex
University of Hertfordshire
University of Cambridge
Paul Beswick is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and pharmacology.
Top concepts
MedicineDrug DiscoveryPharmacologyBiochemistryNatural SciencesPharmacotherapyMedicinal ChemistryOrganic ChemistryEngineeringDrug Development
Publications per year
1984–2025
Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors
Oliver N. F. King, Xuan Shirley Li, Masaaki Sakurai et al. · PLoS ONE · 2010 · 222 citations · Full text
Chelation‐Controlled Intermolecular Hydroacylation: Direct Addition of Alkyl Aldehydes to Functionalized Alkenes
Michael C. Willis, Steven J. McNally, Paul Beswick · Angewandte Chemie International Edition · 2003 · 133 citations
Cross-coupling Reaction, Engineering, Alkene Metathesis +11
Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists
J. W. CLITHEROW, Paul Beswick, W Irving et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 106 citations
Novel 1, Biochemistry, Medicine +6
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
Gemma Mudd, Heather S. Scott, Liuhong Chen et al. · Journal of Medicinal Chemistry · 2022 · 80 citations · Full text
Drug Target, Toxinology, Immunology +17
Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor
Muna Abdi, Paul Beswick, Andy Billinton et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 70 citations · Full text
Molecular Pharmacology, Biochemistry, Medicine +10
1–5 of 32